Pharmacodynamic Effects of Ranolazine Versus Amlodipine on Platelet Reactivity

Summary

No previous study has assessed the potential of ranolazine to interfere with levels of platelet reactivity in patients with coronary artery disease who are treated with dual antiplatelet therapy. Aim of this study is to compare the pharmacodynamic effects of maintenance doses of ranolazine versus amlodipine on platelet reactivity in patients with coronary artery disease who are treated with dual antiplatelet therapy.

Timeline

Start

2012-01

Primary completion

2014-06

Completion

2014-06

Drugs

Indications